PrimeRFP SCOUT · Federal Contract Recompete Brief

W911SR23F0057 — DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE…

DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE… is a federal award for Department of Defense (DOD) held by OLOGY BIOSERVICES, INC.. Estimated value $67.6M ($4.3M obligated). Current period of performance ends Jan 5, 2028.

$67.6M
Estimated Value
$4.3M
Obligated
Jan 5, 2028
PoP End / Expires

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

OLOGY BIOSERVICES, INC. holds $17.9M across 7 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards under parent W911SR22D0009. Recompete timing centers on the Jan 5, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract numberW911SR23F0057
AgencyDepartment of Defense (DOD)
IncumbentOLOGY BIOSERVICES, INC.
UEIGC2RFAZK8G64
NAICS541715
PSCAN42
Parent IDIQ / IDVW911SR22D0009
PoP end (current)Jan 5, 2028
Obligated$4.3M

DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE/STABILITY FOR THE PROGRAM WITH ULTIMATE GOAL OF U.S. F.D.A. LICENSURE OF BONT MAB G03-52-01 DRUG PRODUCT.

Recompete timing

Public
Expiring in 507 days

Current PoP ends Jan 5, 2028 (507 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 5, 2026.

Watch this contract — one email →

Incumbent footprint

Public record

OLOGY BIOSERVICES, INC.$17.9M obligated across 7 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($17.9M) · all agencies
Department of Defense (DOD)$11.6M · 65%Department of Health and Human Services (HHS)$6.3M · 35%
Open full company profile

Related awards

Same parent · incumbent
W911SR22F0073
DS PROCESS CHARACTERIZATION
$10.8M
Jan 5, 2028
W911SR22F0014
CLINICAL DEVELOPMENT PHASE 2 STUDY
$107.9M
Feb 29, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for W911SR23F0057
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open OLOGY BIOSERVICES, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract W911SR23F0057?

W911SR23F0057 (DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE…) is a Department of Defense (DOD) award with an estimated value of $67.6M, currently held by OLOGY BIOSERVICES, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on W911SR23F0057?

OLOGY BIOSERVICES, INC. is the incumbent with $17.9M across 7 related awards in SCOUT’s public footprint. The current period of performance ends Jan 5, 2028.

When does W911SR23F0057 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 5, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W911SR22D0009-W911SR23F0057